Research ExplorerPublicationsReal-World Issues and Potential Solutions in Hematopoietic C...

Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee

Standard

Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee. / Algwaiz, Ghada; Aljurf, Mahmoud; Koh, Mickey; Horowitz, Mary M; Ljungman, Per; Weisdorf, Daniel; Saber, Wael; Kodera, Yoshihisa; Szer, Jeff; Jawdat, Dunia; Wood, William A; Brazauskas, Ruta; Lehmann, Leslie; Pasquini, Marcelo C; Seber, Adriana; Lu, Pei Hua; Atsuta, Yoshiko; Riches, Marcie; Perales, Miguel-Angel; Worel, Nina; Okamoto, Shinichiro; Srivastava, Alok; Chemaly, Roy F; Cordonnier, Catherine; Dandoy, Christopher E; Wingard, John R; Kharfan-Dabaja, Mohamed A; Hamadani, Mehdi; Majhail, Navneet S; Waghmare, Alpana A; Chao, Nelson; Kröger, Nicolaus; Shaw, Bronwen; Mohty, Mohamad; Niederwieser, Dietger; Greinix, Hildegard; Hashmi, Shahrukh K; WBMT and the CIBMTR Health Services and International Studies Committee.

In: BIOL BLOOD MARROW TR, Vol. 26, No. 12, 12.2020, p. 2181-2189.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Algwaiz, G, Aljurf, M, Koh, M, Horowitz, MM, Ljungman, P, Weisdorf, D, Saber, W, Kodera, Y, Szer, J, Jawdat, D, Wood, WA, Brazauskas, R, Lehmann, L, Pasquini, MC, Seber, A, Lu, PH, Atsuta, Y, Riches, M, Perales, M-A, Worel, N, Okamoto, S, Srivastava, A, Chemaly, RF, Cordonnier, C, Dandoy, CE, Wingard, JR, Kharfan-Dabaja, MA, Hamadani, M, Majhail, NS, Waghmare, AA, Chao, N, Kröger, N, Shaw, B, Mohty, M, Niederwieser, D, Greinix, H, Hashmi, SK & WBMT and the CIBMTR Health Services and International Studies Committee 2020, 'Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee', BIOL BLOOD MARROW TR, vol. 26, no. 12, pp. 2181-2189. https://doi.org/10.1016/j.bbmt.2020.07.021

APA

Algwaiz, G., Aljurf, M., Koh, M., Horowitz, M. M., Ljungman, P., Weisdorf, D., Saber, W., Kodera, Y., Szer, J., Jawdat, D., Wood, W. A., Brazauskas, R., Lehmann, L., Pasquini, M. C., Seber, A., Lu, P. H., Atsuta, Y., Riches, M., Perales, M-A., ... WBMT and the CIBMTR Health Services and International Studies Committee (2020). Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee. BIOL BLOOD MARROW TR, 26(12), 2181-2189. https://doi.org/10.1016/j.bbmt.2020.07.021

Vancouver

Algwaiz G, Aljurf M, Koh M, Horowitz MM, Ljungman P, Weisdorf D et al. Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee. BIOL BLOOD MARROW TR. 2020 Dec;26(12):2181-2189. https://doi.org/10.1016/j.bbmt.2020.07.021

Bibtex

@article{17ebd09baf624d9ab2b01cbe935806f9,
title = "Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee",
abstract = "The current COVID-19 pandemic, caused by SARS-CoV-2, has impacted many facets of hematopoietic cell transplantation (HCT) in both developed and developing countries. Realizing the challenges as a result of this pandemic affecting the daily practice of the HCT centers and the recognition of the variability in practice worldwide, the Worldwide Network for Blood and Marrow Transplantation (WBMT) and the Center for International Blood and Marrow Transplant Research's (CIBMTR) Health Services and International Studies Committee have jointly produced an expert opinion statement as a general guide to deal with certain aspects of HCT, including diagnostics for SARS-CoV-2 in HCT recipient, pre- and post-HCT management, donor issues, medical tourism, and facilities management. During these crucial times, which may last for months or years, the HCT community must reorganize to proceed with transplantation activity in those patients who urgently require it, albeit with extreme caution. This shared knowledge may be of value to the HCT community in the absence of high-quality evidence-based medicine. {\textcopyright} 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.",
keywords = "Bone Marrow Transplantation, COVID-19/diagnosis, Hematopoietic Stem Cell Transplantation, Humans, SARS-CoV-2",
author = "Ghada Algwaiz and Mahmoud Aljurf and Mickey Koh and Horowitz, {Mary M} and Per Ljungman and Daniel Weisdorf and Wael Saber and Yoshihisa Kodera and Jeff Szer and Dunia Jawdat and Wood, {William A} and Ruta Brazauskas and Leslie Lehmann and Pasquini, {Marcelo C} and Adriana Seber and Lu, {Pei Hua} and Yoshiko Atsuta and Marcie Riches and Miguel-Angel Perales and Nina Worel and Shinichiro Okamoto and Alok Srivastava and Chemaly, {Roy F} and Catherine Cordonnier and Dandoy, {Christopher E} and Wingard, {John R} and Kharfan-Dabaja, {Mohamed A} and Mehdi Hamadani and Majhail, {Navneet S} and Waghmare, {Alpana A} and Nelson Chao and Nicolaus Kr{\"o}ger and Bronwen Shaw and Mohamad Mohty and Dietger Niederwieser and Hildegard Greinix and Hashmi, {Shahrukh K} and {WBMT and the CIBMTR Health Services and International Studies Committee}",
note = "Copyright {\textcopyright} 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.",
year = "2020",
month = dec,
doi = "10.1016/j.bbmt.2020.07.021",
language = "English",
volume = "26",
pages = "2181--2189",
journal = "BIOL BLOOD MARROW TR",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "12",

}

RIS

TY - JOUR

T1 - Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee

AU - Algwaiz, Ghada

AU - Aljurf, Mahmoud

AU - Koh, Mickey

AU - Horowitz, Mary M

AU - Ljungman, Per

AU - Weisdorf, Daniel

AU - Saber, Wael

AU - Kodera, Yoshihisa

AU - Szer, Jeff

AU - Jawdat, Dunia

AU - Wood, William A

AU - Brazauskas, Ruta

AU - Lehmann, Leslie

AU - Pasquini, Marcelo C

AU - Seber, Adriana

AU - Lu, Pei Hua

AU - Atsuta, Yoshiko

AU - Riches, Marcie

AU - Perales, Miguel-Angel

AU - Worel, Nina

AU - Okamoto, Shinichiro

AU - Srivastava, Alok

AU - Chemaly, Roy F

AU - Cordonnier, Catherine

AU - Dandoy, Christopher E

AU - Wingard, John R

AU - Kharfan-Dabaja, Mohamed A

AU - Hamadani, Mehdi

AU - Majhail, Navneet S

AU - Waghmare, Alpana A

AU - Chao, Nelson

AU - Kröger, Nicolaus

AU - Shaw, Bronwen

AU - Mohty, Mohamad

AU - Niederwieser, Dietger

AU - Greinix, Hildegard

AU - Hashmi, Shahrukh K

AU - WBMT and the CIBMTR Health Services and International Studies Committee

N1 - Copyright © 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.

PY - 2020/12

Y1 - 2020/12

N2 - The current COVID-19 pandemic, caused by SARS-CoV-2, has impacted many facets of hematopoietic cell transplantation (HCT) in both developed and developing countries. Realizing the challenges as a result of this pandemic affecting the daily practice of the HCT centers and the recognition of the variability in practice worldwide, the Worldwide Network for Blood and Marrow Transplantation (WBMT) and the Center for International Blood and Marrow Transplant Research's (CIBMTR) Health Services and International Studies Committee have jointly produced an expert opinion statement as a general guide to deal with certain aspects of HCT, including diagnostics for SARS-CoV-2 in HCT recipient, pre- and post-HCT management, donor issues, medical tourism, and facilities management. During these crucial times, which may last for months or years, the HCT community must reorganize to proceed with transplantation activity in those patients who urgently require it, albeit with extreme caution. This shared knowledge may be of value to the HCT community in the absence of high-quality evidence-based medicine. © 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.

AB - The current COVID-19 pandemic, caused by SARS-CoV-2, has impacted many facets of hematopoietic cell transplantation (HCT) in both developed and developing countries. Realizing the challenges as a result of this pandemic affecting the daily practice of the HCT centers and the recognition of the variability in practice worldwide, the Worldwide Network for Blood and Marrow Transplantation (WBMT) and the Center for International Blood and Marrow Transplant Research's (CIBMTR) Health Services and International Studies Committee have jointly produced an expert opinion statement as a general guide to deal with certain aspects of HCT, including diagnostics for SARS-CoV-2 in HCT recipient, pre- and post-HCT management, donor issues, medical tourism, and facilities management. During these crucial times, which may last for months or years, the HCT community must reorganize to proceed with transplantation activity in those patients who urgently require it, albeit with extreme caution. This shared knowledge may be of value to the HCT community in the absence of high-quality evidence-based medicine. © 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.

KW - Bone Marrow Transplantation

KW - COVID-19/diagnosis

KW - Hematopoietic Stem Cell Transplantation

KW - Humans

KW - SARS-CoV-2

U2 - 10.1016/j.bbmt.2020.07.021

DO - 10.1016/j.bbmt.2020.07.021

M3 - SCORING: Journal article

C2 - 32717432

VL - 26

SP - 2181

EP - 2189

JO - BIOL BLOOD MARROW TR

JF - BIOL BLOOD MARROW TR

SN - 1083-8791

IS - 12

ER -